Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice

Levofloxacin-containing second-line anti-Helicobacter pylori eradication in Taiwanese real-world practice

Background: Quinolone-containing triple therapy is recommended as an option for non-bismuth containing second-line Helicobacter pylori eradication. Current available Taiwanese reports in the literature used 7-day quinolone-containing triple therapy. As a result, some physicians still prescribe 7-day...

Full description

Bibliographic Details
Main Authors: Chih-Ming Liang, Jen-Wen Cheng, Chung-Mou Kuo, Kuo-Chin Chang, Keng-Liang Wu, Wei-Chen Tai, King-Wah Chiu, Shue-Shian Chiou, Ming-Tsung Lin, Tsung-Hui Hu, Seng-Kee Chuah
Format: Article
Language:English
Published: Elsevier 2014-10-01
Series:Biomedical Journal
Subjects:
7-day levofloxacin-containing triple therapy
fluoroquinolone
second-line anti-Helicobacter pylori therapy
Online Access:http://www.biomedj.org/article.asp?issn=2319-4170;year=2014;volume=37;issue=5;spage=326;epage=330;aulast=Liang

Internet

http://www.biomedj.org/article.asp?issn=2319-4170;year=2014;volume=37;issue=5;spage=326;epage=330;aulast=Liang

Similar Items